COVID-19: Understanding What We Know After Five Years

Five years can feel like a lifetime.

In early 2020, COVID-19 transformed ordinary life almost overnight. Schools closed. Offices emptied. Flights were canceled. Hospitals filled. Families became separated, and phrases such as “social distancing,” “lockdown,” “PCR test,” and “quarantine” suddenly became part of everyday language.

Today, the world looks very different.

The emergency phase of the pandemic has passed, but SARS-CoV-2 has not disappeared. COVID-19 continues to circulate, and researchers have spent years learning how the virus behaves, how immunity changes, which people face the greatest risks, how vaccines perform, and why some people experience symptoms long after an infection.

Five years of evidence have replaced many early uncertainties with a much clearer—although still incomplete—picture.

So what do we actually know now?

COVID-19 Is Still With Us

One of the most important lessons is that the end of the emergency phase did not mean the end of COVID-19.

WHO's recent global risk assessment reported that the worldwide public-health risk from COVID-19 remained moderate at the end of 2025, with deaths and hospitalizations substantially lower than during the earlier pandemic years. The improvement has been attributed to high levels of population immunity, better clinical management and relatively stable severity indicators. (WHO)

That is encouraging.

But it doesn't mean COVID-19 has become irrelevant.

The virus continues circulating, and some people—particularly older adults and those with certain medical conditions—remain much more vulnerable to severe disease.

COVID-19 has therefore moved from being an unprecedented emergency toward being a continuing infectious-disease challenge.

The Virus Has Changed

SARS-CoV-2 has evolved considerably since the original virus emerged.

Variants and subvariants have appeared repeatedly, changing how easily the virus spreads and how well previous immunity recognizes it.

Many currently circulating viruses belong to Omicron-related lineages. WHO reported that these lineages demonstrate immune escape compared with earlier variants, while available evidence did not indicate increased disease severity. (WHO)

This evolutionary process is one reason COVID-19 vaccination strategies have changed over time.

Instead of relying permanently on the original vaccine formulations, vaccine compositions can be updated to better match circulating viruses.

WHO's vaccine advisory group continues to review the genetic and antigenic evolution of SARS-CoV-2 and assess whether vaccine composition should be adapted. (Organisation Mondiale de la Santé)

Vaccines Changed the Course of the Pandemic

Perhaps no development has been more consequential than the creation and deployment of COVID-19 vaccines.

The evidence accumulated over several years shows that vaccines are particularly valuable for reducing the risk of severe disease, hospitalization and death.

They were never a guarantee that someone would never become infected.

That distinction is important.

A vaccinated person can still catch COVID-19, particularly as immunity wanes and the virus evolves. But vaccination can provide additional protection against the outcomes that matter most.

WHO reports that more than 13.6 billion COVID-19 vaccine doses had been administered globally by the end of 2024 and continues to recommend vaccination using a risk-based approach. (Organisation Mondiale de la Santé)

WHO also reports that five years of accumulated vaccine-safety data continue to show an acceptable safety profile for currently available mRNA and protein-subunit COVID-19 vaccines, with serious adverse events remaining rare relative to the enormous number of doses administered. (Organisation Mondiale de la Santé)

Protection Changes Over Time

Another lesson from the past five years is that immunity isn't permanent in the sense of providing identical protection forever.

Protection against infection can decline as time passes.

The virus also changes.

That's why updated vaccines have continued to be developed.

In the United States, CDC guidance for the 2025–2026 season recommends COVID-19 vaccination for people aged six months and older using individual-based decision-making. CDC particularly emphasizes vaccination for older adults and people at higher risk of severe disease. (CDC)

The exact recommendations can differ between countries, so people should follow the guidance of their local health authorities and healthcare professionals.

Severe Disease Is Not Distributed Equally

One of the clearest findings from the pandemic is that COVID-19 doesn't affect everyone in the same way.

Age is a major factor.

Older adults are more likely to develop severe illness, and certain medical conditions can further increase risk.

People who are moderately or severely immunocompromised can also face greater risk and may have different vaccination needs. CDC guidance specifically identifies immunocompromised people among groups who may benefit from additional protection. (CDC)

This is why public-health recommendations increasingly focus on risk rather than treating every individual as though they face exactly the same probability of severe disease.

Long COVID Became One of the Most Important Discoveries

Perhaps one of the most significant areas of continuing research is Long COVID, also called post-COVID-19 condition.

Some people recover from the acute infection and then experience symptoms that persist for weeks, months or longer.

Symptoms can include fatigue, difficulty concentrating, shortness of breath, sleep problems, pain and other health problems.

WHO's February 2025 fact sheet states that symptoms generally improve over time, often over four to nine months, but estimates from 2022 suggested that approximately 15% of people with the condition still had symptoms at 12 months. (Organisation Mondiale de la Santé)

Long COVID is important because it demonstrates that the impact of an infectious disease cannot be measured solely by hospitalization or death during the initial infection.

Someone may survive an acute infection and still experience substantial consequences afterward.

Vaccination and Long COVID

Research has also examined whether vaccination affects the risk of Long COVID.

CDC states that studies show people who are vaccinated and subsequently become infected are less likely to develop Long COVID than people who are unvaccinated or not up to date with vaccination. (CDC)

CDC also describes vaccination as the best available tool for preventing Long COVID. (CDC)

This doesn't mean vaccination eliminates the possibility.

It means reducing the risk of infection and severe disease can also reduce the likelihood of some longer-term consequences.

Treatment Has Improved Too

The medical response to COVID-19 has also changed substantially.

During the first months of the pandemic, clinicians were learning in real time.

Doctors and researchers gradually identified which treatments helped and which approaches were ineffective or potentially harmful.

Today, clinicians have substantially more experience managing COVID-19, particularly in patients at high risk of severe disease.

This improved clinical management is one of the reasons the global burden of severe disease has declined compared with the earlier years of the pandemic. (WHO)

But treatment works best when people who are at high risk receive appropriate medical attention early.

What About Reinfection?

Another lesson is that infection does not necessarily provide lifelong protection against future infection.

People can become infected more than once.

The combination of previous infections, vaccination and evolving viral variants creates a complicated landscape of immunity.

Importantly, having previously had COVID-19 doesn't mean someone should assume they can never become infected again.

CDC notes that immunity after infection decreases with time and that vaccine protection also wanes, contributing to the rationale for updated vaccination. (CDC)

The Pandemic Also Changed How We Think About Public Health

COVID-19 wasn't simply a medical event.

It exposed weaknesses in healthcare systems.

It highlighted inequalities.

It demonstrated the importance of reliable scientific communication.

It also showed how quickly misinformation can spread.

One of the biggest lessons may be that public-health communication needs to acknowledge uncertainty.

Science changes because evidence changes.

A recommendation made in 2020 may reasonably be different from one made in 2025 because researchers have vastly more information.

Changing advice isn't necessarily evidence that scientists “didn't know anything.”

Often, it is evidence that they learned something new.

What We Still Don't Know

Five years of research have answered many questions, but not all of them.

Scientists continue studying Long COVID.

Researchers continue monitoring viral evolution.

Questions remain about the long-term effects of repeated infections and how different combinations of infection and vaccination shape immunity.

Surveillance itself has become more difficult in some places.

WHO has warned about gaps in surveillance, reduced genomic sequencing and limitations in the sharing of viral sequence information. (WHO)

That matters because monitoring an evolving virus requires reliable data.

Should We Still Take COVID-19 Seriously?

The answer depends on what “seriously” means.

If it means living as though it is March 2020 forever, the evidence does not support that approach.

But if it means recognizing that COVID-19 remains capable of causing severe illness and death—especially among higher-risk people—the answer is yes.

A balanced approach is possible.

People can live normal lives while still taking sensible precautions when circumstances warrant them.

Someone at higher risk may make different decisions from a healthy younger person.

During periods of increased respiratory-virus circulation, people may choose to improve ventilation, stay home when sick, wear a mask in crowded settings, or avoid exposing vulnerable relatives while ill.

The appropriate level of caution can vary.

What Five Years Have Taught Us

Perhaps the biggest lesson is that infectious diseases are rarely static.

The virus changed.

Human immunity changed.

Vaccines changed.

Treatments changed.

Public-health policies changed.

And our understanding changed.

The pandemic forced researchers to learn at unprecedented speed.

It also taught ordinary people how important scientific evidence can be—and how dangerous it can be when rumors are treated as evidence.

A More Balanced Understanding

Five years later, two extreme ideas should be avoided.

The first is:

“COVID-19 is completely gone, so it doesn't matter anymore.”

That isn't accurate.

The second is:

“Nothing has changed since 2020.”

That isn't accurate either.

The reality is somewhere in between.

COVID-19 remains with us, but population immunity and medical advances have dramatically changed the risk landscape.

WHO's latest assessments describe a substantially lower global risk than during the height of the pandemic, while still recognizing ongoing hospitalizations, deaths and the importance of protection for people at higher risk. (WHO)

Final Thoughts

Five years after COVID-19 changed the world, we understand far more than we did at the beginning.

We know that SARS-CoV-2 continues to evolve.

We know that immunity changes over time.

We know vaccines provide important protection against severe disease.

We know older adults and people with certain health conditions face greater risks.

We know that Long COVID can have lasting effects.

And we know that better treatments and accumulated immunity have helped reduce the devastating impact seen during the earliest years.

But we also know that science is not finished.

There are still unanswered questions, and continued surveillance remains important.

The most useful response isn't panic.

It isn't complacency either.

It is informed awareness.

COVID-19 is no longer the mysterious new threat it was in 2020. But it hasn't disappeared.

Five years of evidence have given us something incredibly valuable: perspective.

And perhaps the most important lesson is that public health works best when curiosity, evidence, humility and compassion remain at the center of the conversation.